Pemetrexed and Cisplatin as Treatment in Small Cell Lung Cancer

Clinical trial NCT00475657 · TERMINATED

Trial details

NCT number: NCT00475657
Sponsor: Eli Lilly and Company
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Small Cell Lung Cancer

Start date: 2007-10-01
Primary completion: 2008-04-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.